ACCELERATED HYPERFRACTIONATED RADIOTHERAPY IN THE TREATMENT FOR INOPERABLE, LOCALLY ADVANCED GASTRIC CANSER

Purpose: to compare survival of patients with locally advanced inoperable gastric cancer (LAIGC), receiving accelerated hyperfractionated (AHF) or conventionally fractionated (CF) radiation therapy (RT). Methods and Materials. Between November 1993 and March 2010, 137 patients with LAIGC receiving CF (2 Gy daily) or AHF (1.3 Gy b.i.d.) to total at least 50 Gy RT in combination or without chemotherapy were retrospectively selected from the hospital database of Arkhangelsk clinical oncological dispensary. Overall survival (OS) assessed using actuarial analysis, Kaplan – Meier method and Cox regression. results. The CF and AHF groups were 102 and 35 patients, respectively. Median follow-up time for all patients was 12 years. By the time of analysis 123 (90 %) patients of all cohort died. Median, 7-year survival were 24 (95 % confidence intervals (CI), 17–31) vs 16 (95 % CI, 11–21) months, hazard ratio (HR)=0.71 (95 % CI, 0.46–1.06), р=0.097; and 19 % (95 % CI 8–34 %) vs 6% (95 % CI 2–13 %) in the AHF and CF groups, respectively. In multivariate OS model the difference decreased to HR=0.87 (95 % CI, 0.49–1.55). The location of the tumor in median third (HR=0.60, 95 % CI, 0.37–0.99 in refer to upper third) was the only independent factor influencing survival.  There was no influence of the total dose in chosen level on survival. conclusion. Our retrospective shows trend towards better OS for those LAIGC patients receiving RT in AHF regimen compared to CF. The prospective randomized study with conformal radiation technics is necessary to confirm these findings.

locally advanced inoperable gastric cancer, radiation therapy, accelerated hyperfractionation, survival

1. Zyryanov B.N., Afanasyev S.G., Zavyalov A.A. Intraoperative radiation therapy using small-sized betatron // Rossijskij onkologicheskij zhurnal. 1998. № 6. P. 32–36. [in Russian]

2. Ruzhnikova A.A., Asakhin S.M., Valkov M.Y. Chemoradiotherapy for locally advanced inoperable gastric cancer: a prospective analysis of survival // Vestnik RNCRR Minzdrava Rossii. 2013. Vol. 13 (2). URL: http://vestnik.rncrr.ru/vestnik/v13/papers/ruzhnikova1_v13.htm (data 30.12.2014). [in Russian]

3. Ruzhnikova A.A., Litinsky S.S., Asakhin S.M., Ruzhnikov A.O., Valkov M.Yu. Chemoradiotherapy for locally advanced inoperable gastric cancer: retrospective analysis of survival // Sibirskij onkologicheskij zhurnal. 2012. № 6. P. 13–20. [in Russian]

4. Guide to chemotherapy of malignant diseases / Ed. By N.I. Perevod- chikova. M.: Prakticheskaja medicina, 2011. 511 p. [in Russian]

5. Oncological service for Russian population in 2012 / Eds. Kap- rin A.D., Starinskij V.V., Petrova G.V. M., 2013. 231 p. [in Russian]

6. Allemani C., Weir H.K., Carreira H., Harewood R., Spika D., Wang X.S., Bannon F., Ahn J.V., Johnson C.J., Bonaventure A., Marcos- Gragera R., Stiller C., Azevedo e Silva G., Chen W.Q., Ogunbiyi O.J., Rachet B., Soeberg M.J., You H., Matsuda T., Bielska-Lasota M., Storm H., Tucker T.C., Coleman M.P. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2) // Lancet. 2015. Vol. 385 (9972). P. 977–1010. doi: 10.1016/S0140-6736(14)62038-9.

7. Horiot J.C., Bontemps P., van den Bogaert W., Le Fur R., van den Weijngaert D., Bolla M., Bernier J., Lusinchi A., Stuschke M., LopezTorrecilla J., Begg A.C., Pierart M., Collette L. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. // Radiother Oncol. 1997. Vol. 44 (2). P. 111–121.

8. International Agency for Research on Cancer. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. URL: http://globocan.iarc.fr/Default.aspx

9. Lee S.S., Kim S.B., Park S.I., Kim Y.H., Ryu J.S., Song H.Y., Shin J.H., Jung H.Y., Lee G.H., Choi K.D., Cho K.J., Kim J.H. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer // Jpn. J. Clin. Oncol. 2007. Vol. 37 (11). P. 829–835.

10. Mantell B.S. Radiotherapy for dysphagia due to gastric carcinoma // Br. J. Surg. 1982. Vol. 69 (2). P. 69–70.

11. Milano M.T., Garofalo M.C., Chmura S.J., Farrey K., Rash C., Heimann R., Jani A.B. Intensity-modulated radiation therapy in the treat- ment of gastric cancer: early clinical outcome and dosimetric compari- son with conventional techniques // Br. J. Radiol. 2006. Vol. 79 (942). P. 497–503.

12. Moertel C.G., Childs D.S. Jr., Reitemeier R.J., Colby M.Y. Jr., Holbrook M.A. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer // Lancet. 1969. Vol. 2 (7626). P. 865–867.

13. Myint A.S. The role of radiotherapy in the palliative treatment of gastrointestinal cancer // Eur. J. Gastroenterol. Hepatol. 2000. Vol. 12 (4). P. 381–390.

14. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Gastric Cancer. URL: http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf

15. Saunders M., Dische S., Barrett A., Harvey A., Griffiths G., Palmar M. Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial. CHART Steering committee // Radiother. Oncol. 1999. Vol. 52 (2). P. 137–148.

16. Schein P., Novak J. (for GITSG) Combined modality therapy (XRT-chemo) versus chemotherapy alone for locally unresectable gastric cancer // Cancer Chemother. Pharmacol. 1982. Vol. 49. P. 1771.

17. Thames H.D. Jr., Withers H.R., Peters L.J., Fletcher G.H. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships // Int. J. Radiat. Oncol. Biol. Phys. 1982. Vol. 8 (2). P. 219–2610.

18. TNM classification of malignant tumours / Ed. by L.H. Sobin, M.K. Gospodarowicz, Ch. Wittekind. 7th edition.

19. Valdagni R. Altered fractionation in radiotherapy // Tumori. 1998. Vol. 84 (2). P. 155–159.

20. Waddell T., Verheij M., Allum W., Cunningham D., Cervantes A., Arnold D. Gastric cancer: ESMO–ESSO–ESTRO Clinical Practice Guide- lines for diagnosis, treatment and follow-up // Ann. Oncol. 2013. Vol. 24 (Suppl. 6): vi57-vi63. doi: 10.1093/annonc/mdt344.

21. Weese J.L, Nussbaum M.L. Gastric cancer – surgical approach // Hematol. Oncol. 1992. Vol. 10 (1). P. 31–35.